Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
89,600,000
-
Total 13F shares
-
37,677,848
-
Share change
-
+37,677,848
-
Total reported value
-
$2,254,530,000
-
Price per share
-
$60.25
-
Number of holders
-
69
-
Value change
-
+$2,254,530,073
-
Number of buys
-
69
Institutional Holders of Verve Therapeutics, Inc. - Common Stock, par value $0.001 per share (VERV) as of Q2 2021
As of 30 Jun 2021 Verve Therapeutics, Inc. - Common Stock, par value $0.001 per share (VERV) had 69 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 37,677,848 shares of stock of the company.
Largest 10 holders included Alphabet Inc., WELLINGTON MANAGEMENT GROUP LLP, FMR LLC, Casdin Capital, LLC, Redmile Group, LLC, BAKER BROS. ADVISORS LP, JANUS HENDERSON GROUP PLC, Rock Springs Capital Management LP, JPMORGAN CHASE & CO, and RA CAPITAL MANAGEMENT, L.P..
This table shows 69 institutional shareholders of the security as of 30 Jun 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.